4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Appili Therapeutics Inc. (APLI) operates in the Biotechnology industry and is headquartered in Halifax, Canada with about 7 employees. Its market capitalization is roughly CAD 1 million. In the fiscal year ended 2026-03-31, APLI reported CAD 0M in revenue and (CAD 4M) in net income.
Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of treatments targeting unmet needs in infectious diseases in the United States and Canada.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | CAD 0M | CAD 0M | CAD 1M | CAD 0M | — |
| Operating Income (EBIT) | (CAD 4M) | (CAD 0M) | (CAD 2M) | (CAD 8M) | — |
| Net Income | (CAD 4M) | (CAD 3M) | (CAD 4M) | (CAD 9M) | — |
CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | CAD 0M | CAD 0M | CAD 0M | CAD 0M | CAD 0M | — |
| Operating Income (EBIT) | (CAD 1M) | (CAD 1M) | (CAD 1M) | (CAD 1M) | (CAD 0M) | — |
| Net Income | (CAD 1M) | (CAD 1M) | (CAD 1M) | (CAD 1M) | CAD 0M | — |
CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | CAD 0M | CAD 0M | CAD 0M | CAD 0M | — |
CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Dividends Paid | CAD 0M | CAD 0M | CAD 0M | CAD 0M | CAD 0M | — |
CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | CAD 2M | CAD 3M | CAD 2M | CAD 3M | — |
| Total Liabilities | CAD 19M | CAD 16M | CAD 12M | CAD 10M | — |
CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive APLI viewer.
About TickerBase · Data methodology & sources · Privacy · Terms